Christopher B. Ehrlich - Feb 3, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Stock symbol
EFTR
Transactions as of
Feb 3, 2022
Transactions value $
$30,750
Form type
4
Date filed
2/7/2022, 08:00 AM
Previous filing
Jan 31, 2022
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $25.8K +5K +100% $5.15 10K Feb 3, 2022 Direct
transaction EFTR Common Stock Purchase $5K +1K +10% $5.00 11K Feb 4, 2022 Direct
holding EFTR Common Stock 142K Feb 3, 2022 By Locust Walk Partners LLC F1
holding EFTR Common Stock 1.03K Feb 3, 2022 By Locust Walk Partners LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.